TLR3 expression correlates with apoptosis, proliferation and angiogenesis in hepatocellular carcinoma and predicts prognosis

The Long Noncoding RNA Expression Profile of Hepatocellular Carcinoma Identified by Microarray Analysis

(2014) Juanjuan Zhu et al.   PLoS One

Matrix metalloproteinase-2 as a target for head and neck cancer therapy

(2012) Ming-Hsien Chien et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Toll-Like Receptor 3 Expressing Tumor Parenchyma and Infiltrating Natural Killer Cells in Hepatocellular Carcinoma Patients

(2012) Valerie Chew et al.   JNCI-Journal of the National Cancer Institute

Hepatocellular carcinoma

(2012) Alejandro Forner et al.   LANCET

Prognosis of Patients with Hepatocellular Carcinoma. Validation and Ranking of Established Staging-Systems in a Large Western HCC-Cohort

(2012) Mark op den Winkel et al.   PLoS One

The functional expression of TLR3 in EPCs impairs cell proliferation by induction of cell apoptosis and cell cycle progress inhibition

(2011) Mei Yang et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Hepatocellular Carcinoma

(2011) Hashem B. El-Serag   NEW ENGLAND JOURNAL OF MEDICINE

Tumoral and angiogenesis factors in hepatocellular carcinoma after locoregional therapy

(2011) Alton B. Farris et al.   PATHOLOGY RESEARCH AND PRACTICE

Poly(I:C) Drives Type I IFN- and TGFβ-Mediated Inflammation and Dermal Fibrosis Simulating Altered Gene Expression in Systemic Sclerosis

(2010) Giuseppina A. Farina et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Toll-like receptor 3 signaling attenuates liver regeneration

(2009) Elina Zorde-Khvalevsky et al.   HEPATOLOGY

Stimulation of Toll-like receptor 3 and 4 induces interleukin-1β maturation by caspase-8

(2008) Jonathan Maelfait et al.   JOURNAL OF EXPERIMENTAL MEDICINE